Investment Summary

Accelmed Invests In Momentis Surgical

On April 12, 2021, private equity firm Accelmed invested in medical products company Momentis Surgical

Investment Highlights
  • This is Accelmed’s 10th transaction in the Medical Products sector.
  • This is Accelmed’s 4th transaction in Israel.

Investment Summary

Date 2021-04-12
Target Momentis Surgical
Sector Medical Products
Investor(s) Accelmed
Deal Type Venture

Target

Momentis Surgical

Or Yehuda, Israel
Momentis Surgical is a medical device company, dedicated to transforming the field of robotic surgery by developing innovative small footprint, cost-effective, robotic-assisted technologies and techniques for a growing number of clinical applications. Momentis Surgical was founded in 2013 and is based in Or Yehuda, Israel.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor
DESCRIPTION

Accelmed is a global investment firm focused on providing investments in small and mid-cap private and public companies. The Firm looks to invest between $20 and $50 million in medical device companies and technologies with revenues between $20 and $70 million. Prospective transaction types include management buyouts and growth financings. Accelmed was formed in 2009 and is based in Miami, Florida.


DEAL STATS #
Overall 13 of 18
Sector (Medical Products) 10 of 12
Type (Venture) 7 of 8
Country (Israel) 4 of 4
Year (2021) 2 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-03-22 MedMinder

Norwood, Massachusetts, United States

MedMinder is a full-service digital pharmacy that is uniquely positioned to meet the needs of elderly and chronically ill patients who require more comprehensive pharmacy service and better engagement with clinical teams. MedMinder empowers thousands of patients to live more independently in their homes while improving their adherence to prescribed medications. MedMinder was founded in 2007 and is based in Norwood, Massachusetts.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-04-21 NeuroPace

Mountain View, California, United States

NeuroPace is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients suffering from drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders. NeuroPace was formed in 1997 and is based in Mountain View, California.

Sell -